Total Payments
$3,976
2024 Payments
$1,118
Companies
46
Transactions
204
Medicare Patients
5,838
Medicare Billing
$906,134
Payment Breakdown by Category
Food & Beverage$3,919 (98.6%)
Education$57.44 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,919 | 201 | 98.6% |
| Education | $57.44 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $566.34 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $520.98 | 35 | $0 (2024) |
| Celgene Corporation | $215.54 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $177.61 | 9 | $0 (2024) |
| PFIZER INC. | $170.24 | 7 | $0 (2024) |
| ABBVIE INC. | $159.54 | 7 | $0 (2024) |
| Amgen Inc. | $158.58 | 9 | $0 (2022) |
| Seagen Inc. | $149.24 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $131.91 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $118.78 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,118 | 53 | Novartis Pharmaceuticals Corporation ($182.95) |
| 2023 | $954.01 | 44 | Merck Sharp & Dohme LLC ($179.41) |
| 2022 | $404.86 | 21 | Celgene Corporation ($72.06) |
| 2021 | $748.02 | 46 | Novartis Pharmaceuticals Corporation ($157.53) |
| 2020 | $393.23 | 23 | Merck Sharp & Dohme Corporation ($90.47) |
| 2019 | $232.32 | 11 | Exelixis Inc. ($79.50) |
| 2018 | $56.29 | 3 | Gilead Sciences, Inc. ($20.56) |
| 2017 | $69.79 | 3 | Janssen Biotech, Inc. ($36.50) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.22 | General |
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: Oncology | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Oncology | ||||||
| 09/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| 09/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Oncology | ||||||
| 09/04/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.59 | General |
| 08/07/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Hematology | ||||||
| 08/01/2024 | PFIZER INC. | INLYTA (Drug), TALZENNA | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Oncology | ||||||
| 07/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $45.79 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,441 | 22,872 | $1.3M | $211,323 |
| 2022 | 30 | 1,624 | 26,230 | $1.6M | $242,597 |
| 2021 | 35 | 1,440 | 19,591 | $1.2M | $229,573 |
| 2020 | 30 | 1,333 | 19,068 | $1.4M | $222,641 |
Total Patients
5,838
Total Services
87,761
Medicare Billing
$906,134
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 218 | 552 | $69,000 | $36,996 | 53.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 34 | 312 | $187,200 | $33,733 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 269 | $76,665 | $27,099 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 215 | 240 | $60,000 | $26,424 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 197 | $44,325 | $13,466 | 30.4% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 45 | 984 | $226,320 | $10,573 | 4.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 26 | 355 | $142,000 | $8,309 | 5.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 33 | 343 | $85,750 | $8,228 | 9.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 55 | $19,250 | $7,961 | 41.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 34 | 502 | $90,360 | $6,510 | 7.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 105 | $29,400 | $5,668 | 19.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $8,410 | $4,221 | 50.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 125 | 494 | $27,170 | $4,063 | 15.0% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 23 | 132 | $19,800 | $2,863 | 14.5% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 27 | 159 | $23,850 | $2,613 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,000 | $1,999 | 33.3% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 15 | 107 | $24,610 | $1,848 | 7.5% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 15 | 63 | $15,750 | $1,641 | 10.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 25 | $3,125 | $1,487 | 47.6% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 14 | 11,850 | $17,175 | $1,453 | 8.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 32 | 54 | $2,700 | $1,446 | 53.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 111 | $9,435 | $1,301 | 13.8% |
| J7120 | Ringers lactate infusion, up to 1000 cc | Office | 2023 | 26 | 188 | $1,880 | $363.37 | 19.3% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 31 | 3,108 | $62,160 | $230.14 | 0.4% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 28 | 192 | $4,800 | $194.50 | 4.1% |
About Dr. Basharath Khan, MD
Dr. Basharath Khan, MD is a Hematology & Oncology healthcare provider based in Rolling Meadows, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1205153053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Basharath Khan, MD has received a total of $3,976 in payments from pharmaceutical and medical device companies, with $1,118 received in 2024. These payments were reported across 204 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($3,919).
As a Medicare-enrolled provider, Khan has provided services to 5,838 Medicare beneficiaries, totaling 87,761 services with total Medicare billing of $906,134. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine
- Location Rolling Meadows, IL
- Active Since 05/03/2010
- Last Updated 10/06/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1205153053
Products in Payments
- KEYTRUDA (Biological) $548.91
- Pomalyst (Drug) $181.81
- KISQALI (Drug) $142.20
- ADCETRIS (Biological) $131.37
- TIBSOVO (Drug) $111.13
- ELIQUIS (Drug) $104.40
- PROMACTA (Drug) $96.78
- LIBTAYO (Biological) $96.07
- Cabometyx (Drug) $79.50
- Fabhalta (Drug) $76.85
- DARZALEX (Biological) $71.93
- LYNPARZA (Drug) $70.26
- IMBRUVICA (Drug) $68.49
- JEMPERLI (Biological) $67.19
- MEKINIST (Drug) $66.43
- ZEJULA (Drug) $64.72
- Nplate (Biological) $64.60
- VENCLEXTA (Drug) $63.26
- Padcev (Drug) $60.31
- INLYTA (Drug) $49.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Rolling Meadows
Roberto Montoya Barraza, Md, MD
Hematology & Oncology — Payments: $28,210
Hematology & Oncology $28,210
Anita Pandey, M.d, M.D
Hematology & Oncology — Payments: $9,728
Hematology & Oncology $9,728
Dr. Manuel Rosado, Md, MD
Hematology & Oncology — Payments: $8,186
Hematology & Oncology $8,186
Lai Xu
Hematology & Oncology — Payments: $7,393
Hematology & Oncology $7,393
Dr. Bassam Matar, Md, MD
Hematology & Oncology — Payments: $4,567
Hematology & Oncology $4,567
Dr. Yirong Zhu, D.o., Ph.d, D.O., PH.D
Hematology & Oncology — Payments: $2,632
Hematology & Oncology $2,632